ILUSTRASI. AstraZeneca Plc's antibody cocktail for Covid-19 prevention has been cleared for use in a medical tourism zone in Hainan, China. REUTERS/Scanpix/Drago Prvulovic
Sumber: Reuters | Editor: Anastasia Lilin Yuliantina
KONTAN.CO.ID - BEIJING. AstraZeneca Plc's antibody cocktail for Covid-19 prevention has been cleared for use in a medical tourism zone in China's southern province of Hainan ahead of national approval. Local media said on Tuesday.
China allows early use of new medical products in the special zone in Qionghai city as a part of several preferential policies granted to the area to promote medical services to visitors from both home and abroad.
Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan atau membeli artikel ini.
Sudah berlangganan? Masuk
Berlangganan Hanya dengan 20rb/bulan Anda bisa mendapatkan berita serta analisis ekonomi, bisnis, dan investasi pilihan
Business Insight, Epaper Harian + Tabloid, Arsip Epaper 30 Hari
Gratis uji coba 7 hari pertama. Anda dapat menggunakan akun Google sebagai metode pembayaran.
